Block 5 - High Yield Flashcards
(103 cards)
Triple drug regiment for maintenance immunotherapy
- Glucocorticoid
- Anti-proliferative
- Cyclosporin or tacrolimus
AE: Cytokine release syndrome
rATG and Alemtuzumab
This drug is humanized anti-CD52 and actively depletes T cells
Ametuzumab
This drug is a humanized antibody that binds CD25 and inhibits T cell proliferation
Basiliximab
MOA of Azathioprine
Azathioprine -> 6-mercaptopurine -> 6-TIMP (inhibits de novo purine biosynthesis) -> 6-TGTP (inhibits CD28/Rac1 T cell costimulation) -> incorporated into DNA -> apoptosis
Inhibition of lymphocyte proliferation
These drugs interact with azothioprine and increase toxicity
Allopurinol and Febuxostat (gout) -> inhibit xanthine oxidase
MOA of mycophenolate mofetil (MMF)
Converted by plasma esterases to mycophenolic acid, which inhibits IMPDH type II, which is required for the S phase of the cell cycle of de novo purine synthesis
AE: progressive multifocal leukoencephalopathy (and what causes it?)
- Mycophenolate mofetil
- Natalizumab
Reactivation of JC virus
Which anti-proliferative is safe to use in pregnant women?
Azathioprine
MOA of cyclosporine and tacrolimus
Diffuse into cell -> cyclosporin binds to cyclophilin and tacrolimus binds to FKBP -> inhibit calcineurin, preventing it from dephosphorylating NFAT, a TF that allows IL-2 to be produced
Which drugs inhibit signal 1 of T cell activation? Which drugs inhibit signal 2?
Signal 1: cyclosporine/tacrolimus
Signal 2: sirolimus/everolimus
AE: nephrotoxicity and hypertension
Cyclosporine/tacrolimus
MOA of sirolimus and everolimus
Bind FKBP, inhibit mTOR, which normally regulates protein synthesis, cell proliferation, and survival downstream of IL-2 binding to its receptor
What types of transplants are sirolimus and everolimus not recommended for and why?
- Liver transplant (risk of hepatic artery thrombosis)
2. Lung transplant (risk of anastomotic dehiscence)
MOA of Ipilimumab
- Binds to CTLA4
- Prevents CTLA4 from binding to CD 80/86 and from delivering a negative signal
- Leaves CD 28 co-stimulation intact
- Leads to enhanced T cell activation
What is Ipilimumab use to treat?
Late stage melanoma
What are Pembrolizumab and Nivolumab used to treat?
Aggressive metastatic cancers
MOA of Pembrolizumab and Nivolumab
- Bind to PD1 protein on T-cells
- Prevent inhibition of T-cell by PD-L1 (found on tumor cells)
- Maintain T cell activation
AE: bradyarrythmia, AV block, varicella zorster virus infection
Fingolimid
___ have many drug interactions due to being metabolized by CYP3A4.
Calcineurin inhibitors (cyclopsorine and tacrolimus)
Broadest spectrum anti-fungal agent
Amphotericin B
Not active against C. lusitaniae, Pseudallescheria boydii
What is Amphotericin B first-line treatment for?
Life-threatening mycotic infections
MOA of Amphotericin B
Binds to Ergosterol, forms a pore in the membrane, increases permeability, efflux of essential molecules, cell death
How is Amphotericin used?
Initial induction therapy (4 weeks) to reduce fungal burden, replaced azoles for consolidation therapy